Cargando…
Sensitivity as outcome measure of androgen replacement: the AMS scale
BACKGROUND: The capacity of the AMS scale as clinical utility and as outcome measure still needs validation. METHODS: An open post-marketing study was performed by office-based physicians in Germany in 2004. We analysed data of 1670 androgen-deficient males who were treated with testosterone gel. Th...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1448206/ https://www.ncbi.nlm.nih.gov/pubmed/16573813 http://dx.doi.org/10.1186/1477-7525-4-23 |